Skip to main content
KOREA PHARMA Co., Ltd. logo

KOREA PHARMA Co., Ltd. — Investor Relations & Filings

Ticker · 032300 ISIN · KR7032300006 KO Manufacturing
Filings indexed 178 across all filing types
Latest filing 2026-05-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 032300

About KOREA PHARMA Co., Ltd.

https://www.koreapharma.co.kr/eng/main/…

KOREA PHARMA Co., Ltd. is a pharmaceutical company established in 1974 that specializes in the development and production of prescription-based medicines. The company has a particular focus on drugs for the Central Nervous System (CNS). Its product portfolio covers a wide range of therapeutic areas, including hepatic, gastrointestinal, antimicrobial, and antihistamine drugs. The company also offers treatments such as amino acids, antibiotics, antidotes, and antiepileptics, aiming to improve and maintain public health through its specialized pharmaceutical products.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean "주식등의 대량보유상황보고서(일반)" which translates to a large (major) shareholding status report disclosing the number and percentage of shares held by a controlling shareholder and related parties. It details holdings, changes, contracts (e.g., collateral loans), and the purpose of holding. This matches our definition for Major Shareholding Notification (Code: MRQ).
2026-05-28 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 85% confidence The document is a voluntary disclosure detailing the issuance results of a private convertible bond (a financing instrument) including amounts, dates, and terms. This is an update on the company's financing activity rather than a broader report or a pure share issuance notice. Therefore it falls under Capital/Financing Update (CAP).
2026-05-28 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 87% confidence The document is an official announcement of the company’s acquisition of its own convertible bonds prior to maturity, detailing bond series, issue date, acquisition amount, rationale, funding source, and method. This is a financing activity affecting the company’s capital structure (reducing outstanding debt). It is not a report of earnings or management changes, nor is it a standalone audit or ESG report. It fits “Capital/Financing Update” (CAP) rather than a share repurchase (POS, which applies to equity) or a generic regulatory notice (RNS).
2026-05-28 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 90% confidence The document is a ‘주요사항보고서(전환사채권 발행결정)’ submitted to the Korean Financial Supervisory Service and Korea Exchange announcing the issuance of convertible bonds (CBs). It provides full terms of the bond issuance (amount, interest, maturity, conversion terms, put/call options, targeted investors, use of proceeds, etc.). This is a material financing update and not merely a summary or call transcript or board change notice. Under our taxonomy, an announcement of fundraising or capital structure change (debt or convertible debt issuance) falls squarely under Capital/Financing Update (CAP).
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is a detailed quarterly report (“분기보고서”) covering the period January 1, 2026 to March 31, 2026, containing extensive business overview, financial data, production figures, and segment results. It is not a brief release or an announcement of a report but the full interim/quarterly filing itself. Hence, it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 93% confidence The document is a ‘주식등의 대량보유상황보고서’ (Report on Holdings of a Large Number of Shares) filed under Korean capital markets law, detailing the number and percentage of shares held by a major shareholder and related parties, changes in holdings, and related contracts. This aligns with a Major Shareholding Notification rather than a financial report or other announcement.
2026-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.